Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles H Reynolds

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
ACS Medicinal Chemistry Letters|July 23, 2014
Protein-ligand cocrystal structures: we can do betterCharles H Reynolds
Future Medicinal Chemistry|August 1, 2015
Ligand efficiency metrics: why all the fuss?Charles H Reynolds
ACS Medicinal Chemistry Letters|September 17, 2025
The New Paradigm in Pharma R&DCharles H Reynolds
Current Pharmaceutical Design|August 17, 2013
Impact of computational structure-based methods on drug discoveryCharles H Reynolds
Journal of Medicinal Chemistry|October 1, 2004
Modeling the protonation states of the catalytic aspartates in beta-secretaseRamkumar Rajamani, Charles H Reynolds
Bioorganic & Medicinal Chemistry Letters|September 3, 2004
Modeling the binding affinities of beta-secretase inhibitors: application to subsite specificityRamkumar Rajamani, Charles H Reynolds
Journal of Chemical Information and Computer Sciences|November 26, 2002
Performance of similarity measures in 2D fragment-based similarity searching: comparison of structural descriptors and similarity coefficientsXin Chen, Charles H Reynolds
Journal of Chemical Information and Modeling|November 8, 2017
Group Additivity in Ligand Binding Affinity: An Alternative Approach to Ligand EfficiencyCharles H Reynolds, Ryan C Reynolds
The Hastings Center Report|May 1, 1997
The (almost) all-new Encyclopedia of BioethicsGlenn C Graber, Charles H Reynolds
Journal of Medicinal Chemistry|May 16, 2003
Calculation of the binding affinity of beta-secretase inhibitors using the linear interaction energy methodBrett A Tounge, Charles H Reynolds
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
ACS Medicinal Chemistry Letters|July 23, 2014
Protein-ligand cocrystal structures: we can do betterCharles H Reynolds
Future Medicinal Chemistry|August 1, 2015
Ligand efficiency metrics: why all the fuss?Charles H Reynolds
ACS Medicinal Chemistry Letters|September 17, 2025
The New Paradigm in Pharma R&DCharles H Reynolds
Current Pharmaceutical Design|August 17, 2013
Impact of computational structure-based methods on drug discoveryCharles H Reynolds
Journal of Medicinal Chemistry|October 1, 2004
Modeling the protonation states of the catalytic aspartates in beta-secretaseRamkumar Rajamani, Charles H Reynolds
Bioorganic & Medicinal Chemistry Letters|September 3, 2004
Modeling the binding affinities of beta-secretase inhibitors: application to subsite specificityRamkumar Rajamani, Charles H Reynolds
Journal of Chemical Information and Computer Sciences|November 26, 2002
Performance of similarity measures in 2D fragment-based similarity searching: comparison of structural descriptors and similarity coefficientsXin Chen, Charles H Reynolds
Journal of Chemical Information and Modeling|November 8, 2017
Group Additivity in Ligand Binding Affinity: An Alternative Approach to Ligand EfficiencyCharles H Reynolds, Ryan C Reynolds
The Hastings Center Report|May 1, 1997
The (almost) all-new Encyclopedia of BioethicsGlenn C Graber, Charles H Reynolds
Journal of Medicinal Chemistry|May 16, 2003
Calculation of the binding affinity of beta-secretase inhibitors using the linear interaction energy methodBrett A Tounge, Charles H Reynolds
Pageof 4